Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Janet A. Stockheim; Jorge J. Daaboul; Ram Yogev; Susan P. Scully; Helen Binns; Ellen Chadwick

doi:10.1016/S0022-3476(99)70467-1

Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Janet A. Stockheim^*, Jorge J. Daaboul, Ram Yogev, Susan P. Scully, Helen Binns, Ellen Chadwick

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

Original language	English (US)
Pages (from-to)	368-370
Number of pages	3
Journal	Journal of Pediatrics
Volume	134
Issue number	3
DOIs	https://doi.org/10.1016/S0022-3476(99)70467-1
State	Published - 1999

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0022-3476(99)70467-1

Cite this

@article{768aece7c0674e768decd851d31b8e1c,

title = "Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate",

abstract = "Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.",

author = "Stockheim, {Janet A.} and Daaboul, {Jorge J.} and Ram Yogev and Scully, {Susan P.} and Helen Binns and Ellen Chadwick",

note = "Funding Information: Drs Stockheim and Chadwick received financial support from Bristol-Myers Squibb, the maker of Megace, to present this research in abstract form at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998. ",

year = "1999",

doi = "10.1016/S0022-3476(99)70467-1",

language = "English (US)",

volume = "134",

pages = "368--370",

journal = "Journal of Pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "3",

}

TY - JOUR

T1 - Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

AU - Stockheim, Janet A.

AU - Daaboul, Jorge J.

AU - Yogev, Ram

AU - Scully, Susan P.

AU - Binns, Helen

AU - Chadwick, Ellen

N1 - Funding Information: Drs Stockheim and Chadwick received financial support from Bristol-Myers Squibb, the maker of Megace, to present this research in abstract form at the Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 1-5, 1998.

PY - 1999

Y1 - 1999

N2 - Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

AB - Symptoms and laboratory evidence of adrenal suppression developed in 2 children with the human immunodeficiency virus after megestrol acetate (MA) therapy was discontinued; both required transient glucocorticoid replacement therapy. High-dose corticotropin stimulation testing performed on children with the human immunodeficiency virus treated or not treated with MA showed that baseline and post-corticotropin cortisol levels were extremely low in 7 of 10 treated patients and normal in 10 of 10 members of a control group (P < .01). MA may suppress adrenal function, and replacement glucocorticoids may prevent or relieve associated symptoms at times of severe stress or on discontinuation of MA therapy.

UR - http://www.scopus.com/inward/record.url?scp=0033499793&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033499793&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(99)70467-1

DO - 10.1016/S0022-3476(99)70467-1

M3 - Article

C2 - 10064680

AN - SCOPUS:0033499793

VL - 134

SP - 368

EP - 370

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -

Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this